Back to search

Netherlands· NL-7ee58ad8e99d

Anidulafungine Accord 100 mg poeder voor concentraat voor oplossing voor infusie

A anidulafungin product containing anidulafungine, registered in Netherlands by Accord Healthcare B.V.. The same ATC class is registered in 16 of our 19 countries.

ATC J02AX06

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedAnidulafungine Accord 100 mg poeder v…ATCJ02AX06REGISTER NO.NL-7ee58ad8e99dPACKS LISTED1CHECKEDSeptember 29, 2026

Where it is registered

Anidulafungin is registered in 16 of 19 countries.

Countries holding a registration under ATC J02AX06 (anidulafungin), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 9 of them publish a price we can compare per daily dose

Anidulafungin · ATC J02AX06

16 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of anidulafungin costs, country by country.

Normalised to the WHO defined daily dose (0.1 g), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Anidulafungin · price per daily dose (0.1 g)

USD · FX 28 Sept 2026

  • CH Switzerland$460.55
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)
Active substance
ANIDULAFUNGINE
Manufacturer
Accord Healthcare B.V.
Country
Netherlands (NL)
ATC code
J02AX06
ATC class
Anidulafungin
Defined daily dose
0.1 g, P
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    120814

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

1 interaction on record for anidulafungin.

Graded by severity as the source publishes them — 1 minor. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Anidulafungin · interactions on record

1 record

Interaction register. Grades as the source publishes them.

Same medicine, other countries

Anidulafungin in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All anidulafungin products

Authorised across Europe · EMA

The same active substance is authorised in 25 EEA countries. Names it is sold under:

  • Austria · Anidulafungin Accord, Anidulafungin Pharmore
  • Belgium · Anidulafungin Sandoz, Anidulafungine Accord Healthcare
  • Bulgaria · Анидулафунгин Ромфарм
  • Czechia · Anidulafungin Accord, Anidulafungin Olikla
  • Germany · Anidulafungin Hexal, Anidulafungin Pharmore
  • Denmark · Anidulafungin ”hikma”, Anidulafungin "sandoz"
  • Estonia · Anidulafungin Sandoz
  • Spain · Anidulafungin Accord, Anidulafungina Hikma
  • Finland · Anidulafungin Accord, Anidulafungin Reig Jofre
  • United Kingdom (Northern Ireland) · Anidulafungin Accord Healthcare, Anidulafungin Reig Jofre Uk
  • Greece · Anidulafungin Accord, Ecafunzor
  • Croatia · Anidulafungin Accord, Anidulafungin Pliva
  • Hungary · Anidulafungin Teva
  • Ireland · Anidulafungin Accord Healthcare Ireland, Anidulafungin Rowex
  • Iceland · Anidulafungin Normon, Ecalta
  • Italy · Anidulafungina Accord
  • Liechtenstein · Ecalta
  • Malta · Ecafunzor
  • Norway · Anidulafungin Accord, Anidulafungin Hikma
  • Poland · Anidulafungin Sandoz, Anidulafungina Accord
  • Portugal · Anidulafungina Accord, Anidulafungina Farmoz
  • Romania · Anidulafungină Accord, Anidulafungină Rompharm
  • Sweden · Anidulafungin Accord, Anidulafungin Hikma
  • Slovenia · Anidulafungin Accord, Anidulafungin Sandoz
  • Slovakia · Anidulafungin Olikla

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/d54311a7-a5f0-4686-9f8e-fe6f91f22b3b
GET /v1/drugs/d54311a7-a5f0-4686-9f8e-fe6f91f22b3b?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Poeder voor concentraat voor oplossing voor infusie",
  "route": "Intraveneus gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h120814_smpc.pdf",
  "strength": null,
  "atc_label": "Anidulafungin",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg120814",
  "excipients": [
    "FRUCTOSE",
    "MANNITOL (D-) (E 421)",
    "MELKZUUR (L-,+ VORM) (E 270)",
    "NATRIUMHYDROXIDE (E 524)",
    "POLYSORBAAT 80 (E 433)",
    "STIKSTOF (HEAD SPACE) (E 941)",
    "ZOUTZUUR (E 507)"
  ],
  "substances": [
    "ANIDULAFUNGINE"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h120814.pdf",
  "authorised_at": "2018/12/04",
  "procedure_number": "NL/H/4543/001",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "120814",
  "additional_monitoring": "N"
}

See everything about anidulafungin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.